A review for solitary plasmacytoma of bone and extramedullary plasmacytoma

dc.contributor.authorKilciksiz S.
dc.contributor.authorKarakoyun-Celik O.
dc.contributor.authorAgaoglu F.Y.
dc.contributor.authorHaydaroglu A.
dc.date.accessioned2024-07-22T08:19:29Z
dc.date.available2024-07-22T08:19:29Z
dc.date.issued2012
dc.description.abstractSolitary plasmacytoma (SP) is characterized by a mass of neoplastic monoclonal plasma cells in either bone (SBP) or soft tissue without evidence of systemic disease attributing to myeloma. Biopsy confirmation of a monoclonal plasma cell infiltration from a single site is required for diagnosis. The common presentation of SBP is in the axial skeleton, whereas the extramedullary plasmacytoma (EMP) is usually seen in the head and neck. The ratio of SP seen at males to females is 2:1 and the median age of patients is 55 years. The incidence rate of SP in black race is approximately 30% higher than the white race. Incidence rate increases exponentially by advancing age. SBP has a significant higher risk for progression to myeloma, and the choice of treatment is radiotherapy (RT) that is applied with curative intent at min. 4000cGy. By only RT application, long-term disease-free survival (DFS) is possible for approximately 30% of patients with SBP and 65% of patients with EMP. Copyright © 2012 Sevil Kilciksiz et al.
dc.identifier.DOI-ID10.1100/2012/895765
dc.identifier.issn1537744X
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/17689
dc.language.isoEnglish
dc.rightsAll Open Access; Gold Open Access; Green Open Access
dc.subjectBone Neoplasms
dc.subjectFemale
dc.subjectHumans
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPlasmacytoma
dc.subjectantineoplastic agent
dc.subjectmelphalan
dc.subjectprednisone
dc.subjectage
dc.subjectbiopsy technique
dc.subjectbone cancer
dc.subjectbone solitary plasmacytoma
dc.subjectcancer adjuvant therapy
dc.subjectcancer diagnosis
dc.subjectcancer growth
dc.subjectcancer incidence
dc.subjectcancer patient
dc.subjectcancer prognosis
dc.subjectcancer radiotherapy
dc.subjectcancer staging
dc.subjectcancer surgery
dc.subjectcancer survival
dc.subjectCaucasian
dc.subjectcell infiltration
dc.subjectdisease free survival
dc.subjecthuman
dc.subjectmyeloma
dc.subjectplasmacytoma
dc.subjectreview
dc.subjectbone tumor
dc.subjectfemale
dc.subjectmale
dc.subjectmiddle aged
dc.subjectmortality
dc.subjectpathology
dc.subjectplasmacytoma
dc.titleA review for solitary plasmacytoma of bone and extramedullary plasmacytoma
dc.typeReview

Files